Macrocyclic Inhibitors of 3C and 3C-like Proteases of Picornavirus, Norovirus, and Coronavirus
No Thumbnail Available
Authors
Mandadapu, Sivakoteswara Rao
Weerawarna, Pathum M.
Prior, Allan M.
Uy, Roxanne Adeline Z.
Aravapalli, Sridhar
Alliston, Kevin R.
Lushington, Gerald H.
Kim, Yunjeong
Hua, Duy H.
Chang, Kyeong-Ok
Advisors
Issue Date
2013-05-16
Type
Article
Keywords
Macrocyclic inhibitor , Proteases , Picornavirus , Norovirus , Coronavirus
Citation
Sivakoteswara Rao Mandadapu,Pathum M. Weerawarna,Allan M. Prior, Roxanne Adeline Z. Uy,Sridhar Aravapalli,Kevin R. Alliston,Gerald H. Lushington,Yunjeong Kim,Duy H. Hua,Kyeong-Ok Chang,William C. Groutas. 2013. Macrocyclic Inhibitors of 3C and 3C-like Proteases of Picornavirus, Norovirus, and Coronavirus. -- Bioorganic & Medicinal Chemistry Letters, available May 16, 2013. ISSN 0960-894X, 10.1016/j.bmcl.2013.05.021
Abstract
The design, synthesis, and in vitro evaluation of the first macrocyclic inhibitor of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus are reported. The in vitro inhibitory activity (50% effective concentration) of the macrocyclic inhibitor toward enterovirus 3C protease (CVB3 Nancy strain), and coronavirus (SARS-CoV) and norovirus 3C-like proteases, was determined to be 1.8, 15.5 and 5.1 μM, respectively.
Table of Contents
Description
Click on the DOI link to access the article (may not be free).
Publisher
Elsevier
Journal
Bioorganic and Medicinal Chemistry Letters
Book Title
Series
PubMed ID
DOI
ISSN
0960-894X